FIRST: ASSESS STABILITYDoes this patient need hospital care?
Unstable or significantly symptomatic flutter with a rapid ventricular response requires immediate hospital assessment.
Concerning findings include:
- Hypotension with poor perfusion.
- Syncope, near-syncope, or altered mental status.
- Ongoing ischemic chest discomfort.
- Severe dyspnea, hypoxemia, or acute heart failure.
Call EMS for instability or severe symptoms.Do not delay transport for outpatient medication adjustments or an EP appointment. The patient should not drive.
When flutter causes hemodynamic instability, synchronized electrical cardioversion is the acute rhythm treatment in an appropriately equipped setting.
01 / PROTECT AGAINST STROKEAssess stroke risk and address anticoagulation
Use the same stroke-risk framework for atrial flutter as for AFib.
1. Calculate CHA2DS2-VASc
Add the points for the patient’s stroke-risk factors. Count only one age category. Include the female-sex point in the total.
2. Start OAC at the recommended threshold
Men: score 2 or higher
OAC is recommended.
Women: score 3 or higher
OAC is recommended.
When this threshold is met, initiate an appropriate oral anticoagulant unless contraindicated, after reviewing bleeding concerns, renal function, interactions, and dose criteria.
Example: Hypertension (1) + diabetes (1) = 2 in a man. Adding the female-sex point gives 3 in a woman. Both meet the recommended threshold.
Intermediate risk: At 1 in men or 2 in women, OAC is reasonable after individualized discussion. Female sex alone does not justify OAC.
These thresholds apply to clinical AF/flutter. Device-detected episodes and other independent anticoagulation indications require their own assessment.
2023 ACC/AHA/ACCP/HRS AF guideline: anticoagulation recommendationsReview renal function, bleeding history, medication interactions, appropriate dosing, and adherence. Aspirin does not replace anticoagulation for flutter-related stroke prevention.
If cardioversion or ablation is being considered, document the rhythm’s duration and any missed anticoagulant doses. The treating team must establish a safe anticoagulation or imaging strategy before an elective procedure.
Anticoagulation generally continues for at least four weeks after successful cardioversion or flutter ablation. Longer-term treatment depends on stroke risk, AFib history, and the follow-up plan—not simply a normal pulse or successful ablation.
02 / CONTROL VENTRICULAR RATESlow the ventricular response
For a stable patient, a beta blocker or diltiazem/verapamil may help slow AV nodal conduction. Choose treatment according to blood pressure, ventricular function, comorbidities, and current medications.
Avoid diltiazem/verapamil in significant LV systolic dysfunction. Acute decompensated heart failure or tenuous blood pressure requires a different treatment approach and often hospital management.
Flutter can be difficult to rate-control. The ventricular rate may remain near 150 despite medication, and escalating therapy can cause hypotension or later bradycardia.
If the rate remains rapid or symptoms persist, expedite cardiology/EP assessment rather than repeatedly increasing medications without a rhythm-control plan.
Slowing the ventricles does not interrupt the flutter circuit or replace stroke prevention.
03 / REFER TO EP EARLYArrange a rhythm-control discussion
Newly diagnosed flutter deserves an early EP discussion, particularly when symptomatic, recurrent, difficult to rate-control, or associated with reduced ventricular function.
- Typical flutter: A defined CTI circuit makes catheter ablation an important treatment option.
- Atypical flutter: Referral allows individualized mapping and discussion of ablation or other rhythm-control options.
- Flutter after AFib ablation or cardiac surgery: Include the prior procedure history because it helps interpret the likely circuit.
Referral does not commit the patient to a procedure. It gives the patient an opportunity to understand and compare treatments.
MAKE THE REFERRAL USEFULWhat should accompany the referral?
- The 12-lead EKG showing flutter, plus prior rhythm recordings if available.
- Symptoms, ventricular rate, blood pressure, and estimated onset.
- Anticoagulant name, dose, adherence, and stroke-risk score.
- Current rate-control medications and response.
- Prior AFib, cardioversion, ablation, or cardiac surgery.
- Relevant CBC, renal function/electrolytes, and thyroid testing when appropriate.
DOCUMENT CLEARLYRecord the rhythm and clinical status
Use “atrial flutter,” with the ventricular rate and clinical status. If the mechanism is uncertain, avoid assigning a circuit based only on the EKG appearance.
Example“Atrial flutter with 2:1 AV conduction, ventricular rate 150 bpm. Hemodynamically stable with exertional dyspnea. Stroke risk and anticoagulation addressed. Expedited EP referral for rhythm-control evaluation.”
The clinic plan: Assess stability. Protect against stroke. Control ventricular rate. Refer to EP.